Blood cancers

Multiple myeloma patients missing out on optimal therapy 

Australian multiple myeloma patients are failing to advance to subsequent lines of therapy and are therefore missing out on newer therapies, a registry study finds. Presenting the findings at Blood 2019, Dr Jessie Zhao from Dorevitch Pathology, in Heidelberg, Melbourne, said recent advances meant there were increased treatment options for multiple myeloma patients but there ...

Already a member?

Login to keep reading.

© 2021 the limbic